Risk of HAART therapy in hepatitis C.
McGovern
Barbara
B
Bica
Ioana
I
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D004347:Drug Interactions; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D012306:Risk
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin